Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Editorial: Drug Repurposing.

Pantziarka P, André N.

Front Med (Lausanne). 2019 Jul 3;6:154. doi: 10.3389/fmed.2019.00154. eCollection 2019. No abstract available.

2.

A Computational Model of Tumor Growth and Anakoinosis.

Pantziarka P, Ghibelli L, Reichle A.

Front Pharmacol. 2019 Mar 26;10:287. doi: 10.3389/fphar.2019.00287. eCollection 2019.

3.

Perioperative Therapies-Using Repurposed Drugs to Improve Cancer Surgery Outcomes.

Pantziarka P, Bouche G.

Cancer J. 2019 Mar/Apr;25(2):100-105. doi: 10.1097/PPO.0000000000000361.

PMID:
30896531
4.

ReDO_DB: the repurposing drugs in oncology database.

Pantziarka P, Verbaanderd C, Sukhatme V, Rica Capistrano I, Crispino S, Gyawali B, Rooman I, Van Nuffel AM, Meheus L, Sukhatme VP, Bouche G.

Ecancermedicalscience. 2018 Dec 6;12:886. doi: 10.3332/ecancer.2018.886. eCollection 2018.

5.

Propranolol and breast cancer-a work in progress.

Pantziarka P, Bryan BA, Crispino S, Dickerson EB.

Ecancermedicalscience. 2018 Jun 18;12:ed82. doi: 10.3332/ecancer.2018.ed82. eCollection 2018.

6.

"Hard" Drug Repurposing for Precision Oncology: The Missing Link?

Pantziarka P, Bouche G, André N.

Front Pharmacol. 2018 Jun 14;9:637. doi: 10.3389/fphar.2018.00637. eCollection 2018. No abstract available.

7.

New uses for old drugs.

Pantziarka P, Pirmohamed M, Mirza N.

BMJ. 2018 Jun 26;361:k2701. doi: 10.1136/bmj.k2701. No abstract available.

PMID:
29945952
8.

Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.

Pantziarka P, Sukhatme V, Crispino S, Bouche G, Meheus L, Sukhatme VP.

Ecancermedicalscience. 2018 Apr 11;12:824. doi: 10.3332/ecancer.2018.824. eCollection 2018.

9.

Does the oncology community have a rejection bias when it comes to repurposed drugs?

Gyawali B, Pantziarka P, Crispino S, Bouche G.

Ecancermedicalscience. 2018 Jan 16;12:ed76. doi: 10.3332/ecancer.2018.ed76. eCollection 2018.

10.

Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.

Verbaanderd C, Maes H, Schaaf MB, Sukhatme VP, Pantziarka P, Sukhatme V, Agostinis P, Bouche G.

Ecancermedicalscience. 2017 Nov 23;11:781. doi: 10.3332/ecancer.2017.781. eCollection 2017.

11.

Perioperative therapies - Enhancing the impact of cancer surgery with repurposed drugs.

Pantziarka P, Bouche G, Sullivan R, Ilbawi AM, Dare AJ, Meheus L.

Eur J Surg Oncol. 2017 Nov;43(11):1985-1988. doi: 10.1016/j.ejso.2017.08.010. Epub 2017 Sep 7.

PMID:
28928011
12.

Repurposing Drugs in Oncology: Next Steps.

Verbaanderd C, Meheus L, Huys I, Pantziarka P.

Trends Cancer. 2017 Aug;3(8):543-546. doi: 10.1016/j.trecan.2017.06.007. Epub 2017 Jul 12.

PMID:
28780930
13.

Scientific advice - is drug repurposing missing a trick?

Pantziarka P.

Nat Rev Clin Oncol. 2017 Aug;14(8):455-456. doi: 10.1038/nrclinonc.2017.69. Epub 2017 May 23. Review. No abstract available.

PMID:
28534529
14.

On paranoid parents.

Pantziarka P.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26440. Epub 2017 Jan 13. No abstract available.

PMID:
28083994
15.

Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.

Pantziarka P, Hutchinson L, André N, Benzekry S, Bertolini F, Bhattacharjee A, Chiplunkar S, Duda DG, Gota V, Gupta S, Joshi A, Kannan S, Kerbel R, Kieran M, Palazzo A, Parikh A, Pasquier E, Patil V, Prabhash K, Shaked Y, Sholler GS, Sterba J, Waxman DJ, Banavali S.

Ecancermedicalscience. 2016 Nov 2;10:689. eCollection 2016.

16.

Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.

Pantziarka P, Bouche G, Sukhatme V, Meheus L, Rooman I, Sukhatme VP.

Ecancermedicalscience. 2016 Oct 12;10:680. eCollection 2016.

17.

Emergent properties of a computational model of tumour growth.

Pantziarka P.

PeerJ. 2016 Jun 29;4:e2176. doi: 10.7717/peerj.2176. eCollection 2016.

18.

Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent.

Pantziarka P, Sukhatme V, Bouche G, Meheus L, Sukhatme VP.

Ecancermedicalscience. 2016 Jan 11;10:610. doi: 10.3332/ecancer.2016.610. eCollection 2016.

19.

The wisdom of crowds and the repurposing of artesunate as an anticancer drug.

Augustin Y, Krishna S, Kumar D, Pantziarka P.

Ecancermedicalscience. 2015 Oct 13;9:ed50. doi: 10.3332/ecancer.2015.ed50. eCollection 2015.

20.

Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.

Sukhatme V, Bouche G, Meheus L, Sukhatme VP, Pantziarka P.

Ecancermedicalscience. 2015 Aug 27;9:568. doi: 10.3332/ecancer.2015.568. eCollection 2015.

21.

Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche.

Pantziarka P.

Ecancermedicalscience. 2015 May 21;9:541. doi: 10.3332/ecancer.2015.541. eCollection 2015.

22.

Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.

Pantziarka P, Sukhatme V, Bouche G, Meheus L, Sukhatme VP.

Ecancermedicalscience. 2015 Apr 15;9:521. doi: 10.3332/ecancer.2015.521. eCollection 2015.

23.

Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.

Van Nuffel AM, Sukhatme V, Pantziarka P, Meheus L, Sukhatme VP, Bouche G.

Ecancermedicalscience. 2015 Feb 24;9:513. doi: 10.3332/ecancer.2015.513. eCollection 2015.

24.

Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy?

Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP.

Future Oncol. 2015;11(2):181-4. doi: 10.2217/fon.14.244. No abstract available.

25.

Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.

Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP.

Ecancermedicalscience. 2014 Nov 26;8:485. doi: 10.3332/ecancer.2014.485. eCollection 2014.

26.

Recycling existing drugs for cancer therapy: delivering low cost cancer care.

Pantziarka P, Cairns L.

Ecancermedicalscience. 2014 Jul 10;8:ed40. doi: 10.3332/ecancer.2014.ed40. eCollection 2014. No abstract available.

27.

Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agent.

Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP.

Ecancermedicalscience. 2014 Jul 10;8:443. doi: 10.3332/ecancer.2014.443. eCollection 2014.

28.

The Repurposing Drugs in Oncology (ReDO) Project.

Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP, Vikas P.

Ecancermedicalscience. 2014 Jul 10;8:442. doi: 10.3332/ecancer.2014.442. eCollection 2014.

29.

Li Fraumeni syndrome, cancer and senescence: a new hypothesis.

Pantziarka P.

Cancer Cell Int. 2013 Apr 15;13(1):35. doi: 10.1186/1475-2867-13-35.

Supplemental Content

Loading ...
Support Center